D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Clozapine for the Treatment-Resistant Schizophrenic
1988 • 4,030 citations
Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine
1992 • 1,420 citations
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
1989 • 1,313 citations
Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET
1986 • 847 citations
Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs
1988 • 692 citations
Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients
1993 • 529 citations
The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs.
1966 • 496 citations
Handbook of Experimental Pharmacology, vol 14.
1972 • 446 citations
An overview of the mechanism of action of clozapine.
1994 • 283 citations
Clozapine: neuroleptic-induced EPS and tardive dyskinesia
1989 • 256 citations
Mechanisms of action of atypical antipsychotic drugs
1991 • 254 citations
5-HT2 and D2 dopamine receptor occupancy in the living human brain
1993 • 228 citations
Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking.
1993 • 190 citations
Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography
1986 • 177 citations
Relationship Between Clinical Efficacy and Clozapine Concentrations in Plasma in Schizophrenia
1993 • 151 citations
No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone
1995 • 146 citations
Serial [18F]N-methylspiroperidol PET studies to measure changes in antipsychotic drug D-2 receptor occupancy in schizophrenic patients
1988 • 140 citations
Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels
1989 • 118 citations
Plasma clozapine concentrations as a predictor of clinical response: a follow-up study.
1994 • 115 citations
High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET
1993 • 108 citations
Evaluation of the Karolinska new positron camera system; the Scanditronix PC2048-15B
1990 • 102 citations
Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection
1988 • 92 citations
Positron Emission Tomography of in-vivo Binding Characteristics of Atypical Antipsychotic Drugs
1996 • 78 citations
Clozapine dose in the United States and Europe: implications for therapeutic and adverse effects.
1994 • 65 citations
Distribution of remoxipride to the human brain and central D2‐ dopamine receptor binding examined in vivo by PET
1990 • 49 citations
Clozapine and D1/D2 Antagonism in Extrapyramidal Functions
1992 • 41 citations
Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study
1995 • 28 citations
Cited By (0)
No citing papers found in database